Proteon Therapeutics Lands $4,338,660 New Financing Round

  • Feed Type
  • Date
    2/19/2014
  • Company Name
    Proteon Therapeutics
  • Mailing Address
    200 West Street Waltham, MA 02451
  • Company Description
    Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring.
  • Website
    http://www.proteontherapeutics.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $4,338,660
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.